- Black PM, Hakim R, Bailey NO. The use of the Codman-Medos Programmable Hakim valve in the management of patients with hydrocephalus: illustrative cases. Neurosurgery 1994; 34:1110-13.
- Faulhauer K, Schmilz P. Overdrainage phenomena in shunt treated hydrocephalus. Acta Neurochir (Wien) 1978; 45:89-101.
- Hakim S. Hydraulic and mechanical mis-matching of valve shunts used in the treatment of hydrocephalus: the need for a servo-valve shunt. Dev Med Child Neural 1973; 15:646-53.
- Hakim S, Duran de la, Roche F, Burton JD. A critical analysis of valve shunts used in the treatment of hydrocephalus. Dev Med Child Neural 1973; 15:230-55.
- Lumenta CB, Roosen N, Dietrich U. Clinical experience with a pressure-adjustable valve SOPHY in the management of hydrocephalus. Childs Nerv Syst 1990; 6:270-4.
- McQuarrie IG, Saint-Louis L, Scherer PB. Treatment of normal pressure hydrocephalus with low versus medium pressure cerebrospinal fluid shunts. Neurosurgery 1984; 15:484-8.
- Schmitt J, Spring A. Therapy of normal pressure hydrocephalus with the transcutaneously magnetically adjustable shunt. Neurochirurgia (Stuttgart) 1990; 33 Suppl 1:23-6.
- Sindou M, Guyotat-Pelissou I, Chidiac A, Goutelle A. Transcutaneous pressure adjustable valve for the treatment of hydrocephalus and arachnoid cysts in adults. Experiences with 75 cases. Acta Neurochir (Wien) 1993; 121:135-9.
- Reinprecht A, Czech T, Dietrich W. Clinical experience with a new pressure-adjustable shunt valve. Acta Neurochir (Wien) 1995; 134:119-24.
- Reinprecht A, Dietrich W, Bertalanffy A, Czech T. The Medos Hakim programmable valve in the treatment of pediatric hydrocephalus. Childs Nerv Syst 1997; 13:588-93.
- Sutcliffe JC, Battersby RD. Do we need variable pressure shunts? Br J Neurosurg 1992; 6:67-70.
- Pikus HJ, Levy ML, Gans W, Mendel E, McComb JG. Outcome, cost analysis, and long-term follow-up in preterm infants with massive grade IV germinal matrix hemorrhage and progressive hydrocephalus. Neurosurgery 1997; 40:983-8.
- McCallum JE, Turbeville D. Cost and outcome in a series of shunted premature infants with intraventricular hemorrhage. Pediatr Neurosurg 1994; 20:63-7.
- Cochrane D, Kestle J, Steinbok P, Evans D, Heron N. Model for the cost analysis of shunted hydrocephalie children. Pediatr Neurosurg 1995; 23:14-19.
- Del Bigio MR. Epidemiology and direct economic impact of hydrocephalus: a community based study. Can J Neurol Sci 1998; 25:123-6.
- Carmel P. Incidence and management of subdural hematoma/hygroma with variable- and fixed-pressure differential valves: a randomized, controlled study of programmable compared with conventional valves. Neurosurgical Focus 1999; 7:Article 7.
- Zemack G, Romner B. Seven years of clinical experience with the programmable Codman Hakim valve: a retrospective study of 583 patients. J Neurosurg 2000; 92:941-8.
- Hakim C. The physics and pathophysiology of the hydraulic complex of the central nervous system. The mechanics of hydrocephalus and normal pressure hydrocephalus. Thesis, Massachusetts Institute of Technology, Cambridge 1985.
- Belliard H, Roux FX, Turak B, Nataf F, Devaux B, Cioloca C. The Codman Medos programmable shunt valve. Evaluation of 53 implantations in 50 patients. Neurochirurgie 1996; 42:139-45.
- Kamiryo T, Fujii Y, Kusaka M, Kashiwagi S, Ito H. Intracranial pressure monitoring using a programmable pressure valve and a telemetric intracranial pressure sensor in a case of slit ventricle syndrome after multiple shunt revisions. Chads Nerv Syst 1991; 7:233-4.
- Miyake H, Ohta T, Kajimoto Y, Matsukawa M. A new ventriculoperitoneal shunt with a telemetric intracranial pressure sensor: clinical experience in 94 patients with hydrocephalus. Neurosurgery 1997; 40:931-5.
- Rohde V, Mayfrank L, Ramakers VT, Gilsbach JM. Four-year experience with the routine use of the programmable Hakim valve in the management of children with hydrocephalus. Acta Neurochir (Wien) 1998; 140:1127-34.
- Aschoff A, Kremer P, Benesch C, Fruh K, Klank A, Kunze S. Overdrainage and shunt technology. A critical comparison of programmable, hydrostatic and variable-resistance valves and flow- reducing devices. Childs Nerv Syst 1995; 11:193-202.
- Czosnyka Z, Czosnyka M, Richards H, Pickard JD. Hydrodynamic properties of hydrocephalus shunts. Acta Neurochir Suppl (Wien) 1998; 71:334-9.
- Trost HA. Is there a reasonable differential indication for different hydrocephalus shunt systems? Chads Nerv Syst 1995; ! 1:189-92.
- Park JK, Frim DM, Schwartz MS, et al The use of clinical practice guidelines (CPGs) to evaluate practice and control costs in ventriculoperitoneal shunt management. Surg Neural 1997,48:536-41.
- Bondurant CP, Jimenez DF. Epidemiology of cerebrospinal fluid shunting. Pediatr Neurosurg 1995; 23:254-8.
- Huffman HJ, Smith MS. The use of shunting devices for cerebrospinal fluid in Canada. Can J Neural Set 1986; 13:81-7.
- Liptak GS, Masiulis BS, McDonald JV. Ventricular shunt survival in children with neural tube defects. Acta Neurochir (Wien). 1985; 74:113-17.
- Kamano S, Nakano Y, Imanishi T, Hattori M. Management with a programmable pressure valve of subdural hematomas caused by a ventriculoperitoneal shunt: case report. Surg Neural 1991,35:381-3.
- Dietrich U, Lumenta C, Sprick C, Majewski B. Subdural hematoma in a case of hydrocephalus and macrocrania. Experience with a pressure-adjustable valve. Childs Nerv Syst 1987; 3:242-4.
- Pickard JD, Bailey S, Sanderson H, Rees M, Garfield JS. Steps towards cost-benefit analysis of regional neurosurgical care. BMJ 1990,301:629-35.
British Journal of Neurosurgery
Volume 15, 2001 - Issue 3